Canada markets closed

IN8bio, Inc. (INAB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0100-0.0100 (-0.98%)
At close: 04:00PM EDT
1.0101 +0.00 (+0.01%)
After hours: 04:18PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
12,827
16,827
14,062
7,347
5,378
Selling General and Administrative
13,745
13,510
14,459
7,306
3,179
Total Operating Expenses
26,572
30,337
28,521
14,653
8,557
Operating Income or Loss
-26,572
-30,337
-28,521
-14,653
-8,557
Total Other Income/Expenses Net
330
330
-
-
-
Income Before Tax
-26,572
-30,007
-28,521
-14,653
-8,557
Income from Continuing Operations
-26,572
-30,007
-28,521
-14,653
-8,557
Net Income
-26,572
-30,007
-28,521
-14,653
-8,557
Net Income available to common shareholders
-26,572
-30,007
-28,521
-14,653
-10,340
Basic EPS
-1.10
-1.00
-1.36
-1.47
-0.53
Diluted EPS
-1.10
-1.00
-1.36
-1.47
-0.53
Basic Average Shares
27,344
29,865
20,968
9,970
19,431
Diluted Average Shares
27,344
29,865
20,968
9,970
19,431